Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 5—May 2003
Research

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

Marianne L.L. van Genugten*Comments to Author , Marie-Louise A. Heijnen*, and Johannes C. Jager*
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 6

Hospitalizations and deaths in various scenarios for alternative complication ratesa

Scenario No. of hospitalizations
 No. of deaths
Base case Hospitalization and death rate
 Base case Hospitalization and death rate
Age group <64 y x 2 Low risk to high risk rate Age group <64 y x 2 Low risk to high risk rate
Nonintervention
 10,186
 12,830
 64,425
 4,040
 4,207
 10,087
Influenza vaccination
Total population
 3,847
 4,376
 16,798
 1,738
 1,771
 3,981
Risk groups
 3,968
 4,617
 50,935
 1,789
 1,873
 5,333
Pneumococcal vaccination
 7,008
 8,857
 58,597
 3,903
 4,066
 9,950
Neuraminidase inhibitors 5,093 6,415 32,212 2,020 2,104 5,043

aSee Table 1.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external